v3.26.1
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Jun. 11, 2026
Oct. 11, 2024
Mar. 31, 2025
Jun. 30, 2026
Dec. 31, 2025
Jun. 06, 2023
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]            
Fair value of common stock $ 4.50     $ 4.53    
Expected volatility 90.00%     95.00%    
Risk-free interest rate 3.80%     3.90%    
Term 4 months     3 months 12 days    
Litigation settlement payable       $ 4,378,904 $ 4,892,059  
Warrant [Member]            
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]            
Exercise price       $ 9.00    
Warrants [Member]            
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]            
Fair value of common stock       $ 12.00    
Expected volatility       86.00%    
Risk-free interest rate       4.82%    
Term       2 years 6 months    
Orient EuroPharma Co., Ltd. [Member]            
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]            
Litigation settlement payable       $ 4,378,904 4,170,000  
Vendor [Member]            
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]            
Litigation settlement payable           $ 600,000
Accrued interest       $ 10,862 7,500  
IPLSA [Member]            
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]            
Litigation settlement payable         $ 722,059  
Line of Credit Agreement [Member] | HCWG [Member]            
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]            
Line of credit   $ 10,000,000.0        
Line of credit, interest rate   10.00%        
Number of warrants to purchase   312,500        
Exercise price   $ 12.00        
Expire date   Oct. 23, 2029        
Warrants exercised     162,500      
Number of shares issuance     162,500      
Line of Credit Agreement [Member] | HCWG [Member] | Warrant [Member]            
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]            
Number of shares of common stock remaining available       150,000